APO Research, Inc.

Find your market.

Compare the product scope, applications and research editions relevant to your next decision.

Our research approach
Browse the complete product directory →

9,053 topics, 45,265 reports

Clear all filters

Pharma & Healthcare

Mitomycin

Mitomycin is an antibiotic which acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.).

Types
2 mg · 10 mg · 20 mg
Applications
Cancer Treatment · Ophthalmic Use · Others

5 editions1 January 2026

View 5 research editions
$2,950Single user · USD · Industry ResearchExplore product: MitomycinCompare research options for Mitomycin
APO Research, Inc.